Delivery of DNA mixed with a degradable matrix carrier was supposed to improve transgene expression. Using a rabbit hind-limb ischemia model, we tested the angiogenic potency of plasmid encoding human vascular endothelial growth factor (pSG5-VEGF165) entrapped in fibrin sealant. Animals were injected intramuscularly with 500 microg of pSG5-VEGF165 or control plasmid, dissolved in saline (PBS) or fibrin glue. After 14 days, presence of delivered constructs and expression of transgene was confirmed in injected muscles of all animals. There were no significant differences in the levels of human VEGF mRNA and protein between VEGF-PBS and VEGF-fibrin groups (Mann-Whitney test). Accordingly, pSG5-VEGF165 regardless of the way of delivery, induced similar increases in capillary density within treated muscles (ANOVA). Control plasmid did not show any effects. In conclusion, injection of pSG5-VEGF165 into ischemic adductor muscle leads to synthesis of human VEGF and increases the number of capillaries. Fibrin carrier does not influence its angiogenic potential.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/039139880302600211 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Efficacy of injectable platelet-rich fibrin (i-PRF) as a novel vehicle for local drug delivery in non-surgical periodontal pocket therapy: A randomized controlled clinical trial.
J Adv Periodontol Implant Dent
September 2024
Department of Periodontics, Saveetha Dental College & Hospitals, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamilnadu, India.
Background: The vehicle in a local drug delivery (LDD) system plays a vital role in delivering the active drug component at the diseased site. Liquid/injectable platelet-rich fibrin (i-PRF), an autologous fibrin matrix, might be used as a vehicle to enmesh drugs and deliver locally at the periodontally diseased sites. This study evaluated the efficacy of the drug (ciprofloxacin [Cip])-loaded i-PRF as a LDD system adjunct to subgingival debridement in subjects with periodontal pockets.
View Article and Find Full Text PDFOn-Site Self-Penetrating Nanomedicine Enabling Dual-Priming Drug Activation and Inside-Out Thrombus Ablation.
ACS Nano
December 2024
Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, PR China.
Main conventional antithrombotic therapies often suffer from unsatisfactory treatment outcomes and the risk of undesirable tissue hemorrhage. Deep clot penetration, on-demand drug activation, and release within the clots remain significant challenges. While past efforts to develop nanomedicines and prodrugs have improved safety at the expense of therapeutic effects.
View Article and Find Full Text PDFMicro-thin hydrogel coating integrated in 3D printing for spatiotemporal delivery of bioactive small molecules.
Biofabrication
November 2024
Center for Dental and Craniofacial Research, College of Dental Medicine, Columbia University Medical Center, 630 W. 168th Street, VC12-210, New York, NY 10032, United States of America.
Three-dimensional (3D) printing incorporated with controlled delivery is an effective tool for complex tissue regeneration. Here, we explored a new strategy for spatiotemporal delivery of bioactive cues by establishing a precise-controlled micro-thin coating of hydrogel carriers on 3D-printed scaffolds. We optimized the printing parameters for three hydrogel carriers, fibrin cross-linked with genipin, methacrylate hyaluronic acid, and multidomain peptides, resulting in homogenous micro-coating on desired locations in 3D printed polycaprolactone microfibers at each layer.
View Article and Find Full Text PDFThe Role of Autologous Platelet Concentrates as a Local Antibiotic Delivery System: A Systematic Scoping Review.
Antibiotics (Basel)
September 2024
Department of Neurosciences, Reproductive Sciences and Oral Sciences, Section of Oral Surgery, University of Naples Federico II, 80131 Naples, Italy.
Article Synopsis
- Ongoing research aims to improve local antibiotic delivery using autologous platelet concentrates (APCs) to reduce side effects and resistance while enhancing tissue penetration.* -
- A systematic review analyzed studies (13 articles total) on the effectiveness of APCs in local antibiotic delivery, confirming their ability to load and release various antibiotics.* -
- The findings suggest that using antibiotics with APCs can effectively release antimicrobials, potentially lowering post-operative infection rates and complementing systemic treatments while maintaining healing benefits.*
Reduced Plasma Selenoprotein P Is Associated With Type I Antithrombin Deficiency and a Prothrombotic State.
Arch Pathol Lab Med
September 2024
From Krakow Centre for Medical Research and Technologies, St. John Paul II Hospital, Kraków, Poland (Klajmon, Natorska, Kopytek, Ząbczyk).
Context.—: A positive association between antithrombin activity and selenium level was reported. Selenoprotein P, the most important selenium carrier, was identified within human plasma fibrin clots.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!